Alcoholic Hepatitis
71
10
11
39
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
3 terminated out of 71 trials
92.9%
+6.3% vs benchmark
20%
14 trials in Phase 3/4
26%
10 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 39 completed trials
Clinical Trials (71)
HA35 Moderate Alcoholic Hepatitis (AH) Study
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
A-TANGO Phase 2 Study
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Short Course Steroids in Alcohol Associated Hepatitis
Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Chronic Hepatitis B Virus Infection in Zambia
Outcomes Using MARS for Patients With ALF
Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
Intra-Hepatic Microbiota in Alcoholic Hepatitis
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment
Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone
A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis
IL-1 Signal Inhibition in Alcoholic Hepatitis
Alcoholic Hepatitis Network Observational Study
Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis